Pamisel, Investor Searches Surge... Stock Price 20,250 Won (0.25%)
Recently, there has been a surge in search frequency for Pharmicell, a bio-pharmaceutical company known for developing the world's first stem cell therapy.
As of 1:31 PM on the 14th, Pharmicell's stock price is 20,250 KRW, up 0.25% from the previous day, with a trading volume of 682,814 shares, which is about 30.57% of the 5-day average trading volume. Foreign investors have tentatively been recorded as net buyers of 7,742 shares today.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Insisting on Phone Consultations Only for Hearing-Impaired Clients"... Human Rights Commission Recommends Staff Training for Foundation
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
[Table] Net Trading Volume of Foreign and Institutional Investors (Unit: shares)
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
